These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31655039)

  • 1. Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI.
    Schaefer M; Buchmueller A; Dittmer F; Straßburger J; Wilmen A
    J Mol Biol; 2019 Dec; 431(24):4817-4833. PubMed ID: 31655039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa.
    Geng Y; Verhamme IM; Sun MF; Bajaj SP; Emsley J; Gailani D
    J Thromb Haemost; 2013 Jul; 11(7):1374-84. PubMed ID: 23617568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia.
    Kar S; Mottamal M; Al-Horani RA
    ChemistryOpen; 2020 Nov; 9(11):1161-1172. PubMed ID: 33204588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism underlying activation of factor IX by factor XIa.
    Gailani D; Geng Y; Verhamme I; Sun MF; Bajaj SP; Messer A; Emsley J
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S48-51. PubMed ID: 24759143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Basis for Activity and Specificity of an Anticoagulant Anti-FXIa Monoclonal Antibody and a Reversal Agent.
    Ely LK; Lolicato M; David T; Lowe K; Kim YC; Samuel D; Bessette P; Garcia JL; Mikita T; Minor DL; Coughlin SR
    Structure; 2018 Feb; 26(2):187-198.e4. PubMed ID: 29336885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution crystal structures of factor XIa coagulation factor in complex with nonbasic high-affinity synthetic inhibitors.
    Fradera X; Kazemier B; Carswell E; Cooke A; Oubrie A; Hamilton W; Dempster M; Krapp S; Nagel S; Jestel A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Apr; 68(Pt 4):404-8. PubMed ID: 22505407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelets in regulating activated coagulation factor XI activity.
    Reitsma SE; Pang J; Raghunathan V; Shatzel JJ; Lorentz CU; Tucker EI; Gruber A; Gailani D; McCarty OJT; Puy C
    Am J Physiol Cell Physiol; 2021 Mar; 320(3):C365-C374. PubMed ID: 33471623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the FXIa catalytic domain in complex with ecotin mutants reveal substrate-like interactions.
    Jin L; Pandey P; Babine RE; Gorga JC; Seidl KJ; Gelfand E; Weaver DT; Abdel-Meguid SS; Strickler JE
    J Biol Chem; 2005 Feb; 280(6):4704-12. PubMed ID: 15545266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the discovery and development of factor XI/XIa inhibitors.
    Al-Horani RA; Afosah DK
    Med Res Rev; 2018 Sep; 38(6):1974-2023. PubMed ID: 29727017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring human antibodies against two distinct functional domains in the heavy chain of FXI/FXIa.
    De La Cadena RA; Baglia FA; Johnson CA; Wenk RE; Amernick R; Walsh PN; Colman RW
    Blood; 1988 Nov; 72(5):1748-54. PubMed ID: 2460161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa.
    Bar Barroeta A; van Galen J; Stroo I; Marquart JA; Meijer AB; Meijers JCM
    J Thromb Haemost; 2019 Dec; 17(12):2047-2055. PubMed ID: 31519061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2.
    Navaneetham D; Jin L; Pandey P; Strickler JE; Babine RE; Abdel-Meguid SS; Walsh PN
    J Biol Chem; 2005 Oct; 280(43):36165-75. PubMed ID: 16085935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.
    Al-Horani RA; Desai UR
    J Med Chem; 2014 Jun; 57(11):4805-18. PubMed ID: 24844380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
    Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
    J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment-Based Lead Generation of 5-Phenyl-1
    Wei Q; Zheng Z; Zhang S; Zheng X; Meng F; Yuan J; Xu Y; Huang C
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30103465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.
    Wu W; Sinha D; Shikov S; Yip CK; Walz T; Billings PC; Lear JD; Walsh PN
    J Biol Chem; 2008 Jul; 283(27):18655-64. PubMed ID: 18441012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design.
    Fjellström O; Akkaya S; Beisel HG; Eriksson PO; Erixon K; Gustafsson D; Jurva U; Kang D; Karis D; Knecht W; Nerme V; Nilsson I; Olsson T; Redzic A; Roth R; Sandmark J; Tigerström A; Öster L
    PLoS One; 2015; 10(1):e0113705. PubMed ID: 25629509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of factor XI inhibition on tumor cell-induced coagulation activation.
    Mäder J; Rolling CC; Voigtländer M; Schulenkorf A; Lehr C; Regenhardt J; Bokemeyer C; Beckmann L; Langer F
    J Thromb Haemost; 2024 Jan; 22(1):199-212. PubMed ID: 37751848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a heparin binding site on the heavy chain of factor XI.
    Zhao M; Abdel-Razek T; Sun MF; Gailani D
    J Biol Chem; 1998 Nov; 273(47):31153-9. PubMed ID: 9813019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.